Ourofino SA. Stock Analysis OFSA3.SA

Ourofino SA engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals. The Company’s activities are divided into three categories: production animals; companion animals; and international operations. The production animals segment represents the manufacture and sale in the domestic market of vaccines and veterinary products for animals, including ruminants, poultry, swine and horses. The companion animal segment is responsible for the manufacture and sale of veterinary products for dogs and cats. The Company’s portfolio includes otological, dermatological, nutritional, antibiotic, anti-inflammatory, antiparasitic products, as well as diagnostic kits and disinfectants. The international operations segment represents the production of vaccines and veterinary products for the foreign market, including Mexico and Colombia.